Prediction of pancreatic atrophy after steroid therapy using equilibrium phase contrast CT imaging in autoimmune pancreatitis

Prediction of pancreatic atrophy after steroid therapy using equilibrium phase contrast CT imaging in autoimmune pancreatitis - Equilibrium CT and pancreatic atrophy in AIP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037491

Enrollment

Registered

2019-07-25

Start date

2018-10-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autoimmune pancreatitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. AIP patients who could be obtained clinical information and prognosis 2. From December 2005 to December 2017, AIP patients treated with steroid therapy, who underwent CE-CT in Kobe university hospital, were enrolled in this study.

Exclusion criteria

Exclusion criteria: Patients for whom consent could not be obtained

Design outcomes

Primary

Measure	Time frame
to evaluate the predictive ability of equilibrium phase CT imaging for pancreatic atrophy after steroid therapy in autoimmune pancreatitis	—

Countries

Japan

Contacts

Public ContactYasutaka Yamada

Department of Internal Medicine, Kobe University Graduate School of Medicine Division of Gastroenterology

kmuvfbi@yahoo.co.jp078-382-6305

Outcome results